Additionally, LINC00511 was also demonstrated to downregulate the expressions of KLF2 and LATS2 by promoting the binding of LSD1 to the promoter regions of LATS2 and KLF2 in lung cancer cells [33]. Here, LINC00511 is linked to lung carcinoma.